Atlas Trials

Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm

Clinical trial NCT04423341 · COMPLETED

Trial details

NCT number
NCT04423341
Sponsor
Silkiss Eye Surgery
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
BlepharospasmBlepharospasm, Benign EssentialCBD
Start date
2020-05-20
Primary completion
2021-03-22
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.